We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$10.5B
AUM Growth
-$388M
Cap. Flow
-$87.6M
Cap. Flow %
-0.84%
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$120M
2
CHRD icon
Chord Energy
CHRD
+$106M
3
EA icon
Electronic Arts
EA
+$96.9M
4
DGX icon
Quest Diagnostics
DGX
+$89.2M
5
ST icon
Sensata Technologies
ST
+$76.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.43%
2 Technology 19.78%
3 Energy 7.84%
4 Industrials 7.21%
5 Financials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIL icon
326
Gildan
GIL
$10.2B
$5.77M 0.06%
+152,110
New +$5.5M
HA
327
DELISTED
Hawaiian Holdings, Inc.
HA
$5.72M 0.05%
459,999
-325,418
-41% -$4.25M
BRBR icon
328
BellRing Brands
BRBR
$1.51B
$5.69M 0.05%
99,574
+49,703
+100% +$2.85M
TWLO icon
329
Twilio
TWLO
$29.8B
$5.63M 0.05%
+99,120
New +$5.85M
ZVRA icon
330
Zevra Therapeutics
ZVRA
$594M
$5.62M 0.05%
1,147,583
+137,966
+14% +$654K
USPH icon
331
US Physical Therapy
USPH
$1.18B
$5.54M 0.05%
59,951
-4,589
-7% -$464K
TME icon
332
Tencent Music
TME
$15.6B
$5.3M 0.05%
377,064
-274,244
-42% -$3.68M
VRDN icon
333
Viridian Therapeutics
VRDN
$2.13B
$5.22M 0.05%
400,915
-38,007
-9% -$526K
SMTC icon
334
Semtech
SMTC
$11.1B
$5.13M 0.05%
171,645
+69,593
+68% +$2.43M
URGN icon
335
UroGen Pharma
URGN
$1.88B
$5.1M 0.05%
+303,740
New +$4.32M
SHAK icon
336
Shake Shack
SHAK
$2.61B
$5.09M 0.05%
56,569
+831
+1% +$81.1K
TERN
337
DELISTED
Terns Pharmaceuticals
TERN
$5.07M 0.05%
+745,044
New +$4.51M
COGT icon
338
Cogent Biosciences
COGT
$6.64B
$5.06M 0.05%
600,098
-98,280
-14% -$745K
OLK
339
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$5.06M 0.05%
198,413
-1,473,856
-88% -$35.1M
ZS icon
340
Zscaler
ZS
$25B
$5.03M 0.05%
26,183
+22,567
+624% +$4.02M
RXRX icon
341
Recursion Pharmaceuticals
RXRX
$1.69B
$4.98M 0.05%
+664,450
New +$5.8M
HLF icon
342
Herbalife
HLF
$1.32B
$4.91M 0.05%
+472,473
New +$4.72M
AGIO icon
343
Agios Pharmaceuticals
AGIO
$1.82B
$4.89M 0.05%
+113,378
New +$4.09M
SKIN icon
344
SkinHealth Systems
SKIN
$90.6M
$4.8M 0.05%
2,502,320
-622,996
-20% -$1.75M
AKRO
345
DELISTED
Akero Therapeutics
AKRO
$4.7M 0.04%
200,432
+71,991
+56% +$1.54M
PBH icon
346
Prestige Consumer Healthcare
PBH
$2.46B
$4.69M 0.04%
+68,048
New +$4.61M
MRNS
347
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4.66M 0.04%
3,979,605
+2,792,824
+235% +$6.99M
ABSI icon
348
Absci
ABSI
$1.34B
$4.54M 0.04%
1,475,076
+891
+0.1% +$4.13K
EDIT icon
349
Editas Medicine
EDIT
$407M
$4.53M 0.04%
970,491
+75,491
+8% +$426K
BIRK icon
350
Birkenstock
BIRK
$7.15B
$4.51M 0.04%
+82,864
New +$4.11M

Similar funds

Woodline Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.

  • Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
  • Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
  • Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
  • Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
  • Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
  • Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
  • Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.